Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.
暂无分享,去创建一个
M. Albert | A. Pandey | A. Madugundu | S. Renuse | A. Bakker | J. Jung | A. Moghekar | Seul Kee Byeon | Ankit P Jain | Anil K. Madugundu | Jacqueline A. Darrow | F. Bhat | A. Pandey | A. Pandey
[1] Dae-Young Lee,et al. UPLC-QqQ/MS-Based Lipidomics Approach To Characterize Lipid Alterations in Inflammatory Macrophages. , 2017, Journal of proteome research.
[2] Michelle K. Lupton,et al. Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease , 2016, Journal of Alzheimer's disease : JAD.
[3] Podcasy Jl,et al. Considering Sex and Gender in Alzheimer Disease and Other Dementias , 2016 .
[4] C. Epperson,et al. Considering sex and gender in Alzheimer disease and other dementias , 2016, Dialogues in clinical neuroscience.
[5] Navdeep S. Chandel,et al. Fundamentals of cancer metabolism , 2016, Science Advances.
[6] H. Khalil,et al. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier? , 2015, Current clinical pharmacology.
[7] Brooke L. Barnette,et al. Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer’s disease subjects , 2015, Acta Neuropsychiatrica.
[8] M. Murshed,et al. Sphingolipid metabolism and its role in the skeletal tissues , 2014, Cellular and Molecular Life Sciences.
[9] A. Fitzpatrick,et al. Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study. , 2014, Atherosclerosis.
[10] H. Soininen,et al. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease , 2014, Neurobiology of Aging.
[11] Tzeng-Ji Chen,et al. Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study , 2014, PloS one.
[12] P. Kamphuis,et al. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.
[13] Torsten Doenst,et al. Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production , 2013, Circulation research.
[14] N. Pfanner,et al. Role of Phosphatidylethanolamine in the Biogenesis of Mitochondrial Outer Membrane Proteins* , 2013, The Journal of Biological Chemistry.
[15] Jin-Ming Yang,et al. Altered energy metabolism in cancer , 2013, Cancer biology & therapy.
[16] J. Vance,et al. Phosphatidylethanolamine Deficiency in Mammalian Mitochondria Impairs Oxidative Phosphorylation and Alters Mitochondrial Morphology* , 2012, The Journal of Biological Chemistry.
[17] N. Pfanner,et al. Phosphatidylethanolamine and Cardiolipin Differentially Affect the Stability of Mitochondrial Respiratory Chain Supercomplexes , 2012, Journal of molecular biology.
[18] C. Lyketsos,et al. Serum ceramides increase the risk of Alzheimer disease , 2012, Neurology.
[19] N. Nalivaeva,et al. Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling , 2012, Front. Physio..
[20] L. Mucke,et al. Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.
[21] Romana Höftberger,et al. Peroxisomal alterations in Alzheimer’s disease , 2011, Acta Neuropathologica.
[22] G. D. Paolo,et al. Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Neuroscience.
[23] Markus R Wenk,et al. Lipidomics: New Tools and Applications , 2010, Cell.
[24] L. Mucke,et al. Phospholipase A2 and arachidonic acid in Alzheimer's disease. , 2010, Biochimica et biophysica acta.
[25] C. Gong,et al. Deregulation of sphingolipid metabolism in Alzheimer's disease , 2010, Neurobiology of Aging.
[26] R. Wurtman,et al. Use of phosphatide precursors to promote synaptogenesis. , 2009, Annual review of nutrition.
[27] A. Draguhn,et al. Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum. , 2009, Human molecular genetics.
[28] J. Wands,et al. Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed , 2008, Journal of diabetes science and technology.
[29] R. Schneiter,et al. Lipid signalling in disease , 2008, Nature Reviews Molecular Cell Biology.
[30] M. Saito,et al. Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: Consequences to morphology and viability on enzyme suppression in cultured primary neurons , 2008, Brain Research.
[31] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[32] M. Hayden,et al. Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant Aβ in plasma , 2006, Neurobiology of Disease.
[33] I. Akiguchi,et al. Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis , 2005, Neuroscience.
[34] Xianlin Han. Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. , 2005, Current Alzheimer research.
[35] J. Wands,et al. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.
[36] D. Sparks,et al. Is there a characteristic lipid profile in Alzheimer's disease? , 2005, Journal of Alzheimer's disease : JAD.
[37] S. Hoyer. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. , 2004, European journal of pharmacology.
[38] C. Kahn,et al. Role for neuronal insulin resistance in neurodegenerative diseases , 2004 .
[39] M. Mattson,et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] V. Zaremberg,et al. Cell membranes and apoptosis: role of cardiolipin, phosphatidylcholine, and anticancer lipid analogues. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[41] J. Pettegrew,et al. Brain Membrane Phospholipid Alterations in Alzheimer's Disease , 2001, Neurochemical Research.
[42] W. Markesbery,et al. Regional Membrane Phospholipid Alterations in Alzheimer's Disease , 2004, Neurochemical Research.
[43] P. Carmeliet,et al. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata. , 2003, Human molecular genetics.
[44] W. Aronow,et al. Association of abnormal serum lipids in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[45] G. Durand,et al. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus , 2003, Neurobiology of Aging.
[46] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[47] Xianlin Han,et al. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.
[48] Xianlin Han,et al. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.
[49] A. Di Biase,et al. Diet, Lipids and Brain Development , 2000, Developmental Neuroscience.
[50] Takeshi Noda,et al. A ubiquitin-like system mediates protein lipidation , 2000, Nature.
[51] R. Martins,et al. Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype , 2000, Annals of the New York Academy of Sciences.
[52] J. Brouwers,et al. Rapid separation and identification of phosphatidylethanolamine molecular species. , 1999, Journal of Lipid Research.
[53] S. Rapoport,et al. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain , 1995, Brain Research.
[54] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[55] K. Kristensson,et al. Lipid Composition in Different Regions of the Brain in Alzheimer's Disease/Senile Dementia of Alzheimer's Type , 1992, Journal of neurochemistry.
[56] J. Growdon,et al. Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Hawthorne,et al. Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains , 1987, Journal of neurochemistry.